Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTX TNA2 |
Rat astrocyte cell line | ATCC CRL-2006 | Rat | brain | cell line | adherent | plasmid | Metafectene | publication | S. Couillard-Despres et al., 2014, US 8,841,430 | Link | ||
CTX TNA2 |
Rat astrocyte cell line | ATCC CRL-2006 | Rat | brain | cell line | adherent | plasmid | Metafectene | publication | C. Karl et al., J Neurochemistry, 2005, 92, 264-282 | |||
D238med |
Human brain medulloblastoma cell line | ATCC HTB-185 | Human | brain | cell line | suspension | plasmid | Metafectene | publication | C. Karl et al., J Neurochemistry, 2005, 92, 264-282 | |||
D283 Med |
Human medulloblastoma cell line | ATCC HTB-185 | Human | nervous system | cell line | suspension | plasmid | Metafectene | publication | S. Couillard-Despres et al., 2014, US 8,841,430 | Link | ||
D3WT_N2Euro |
Mouse neural stem cell line (Derivat of mES line D3) | Mouse | unknown | stem cell | adherent | iron oxide | Metafectene | publication | M. H. Keuters et al., NMR Biomed., 2015, 28: 231-239; DOI: 10.1002/nbm.3244 | ||||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
Dami |
Human megakaryocytic cells | Human | other | cell line | plasmid | K4 Transfection System | application note | ![]() |
|||||
Daoy |
Human desmoplastic cerebellar medulloblastoma cell line | ATCC HTB-186 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
DC2.4 |
Mouse dendritic cell line | Mouse | bone | cell line | siRNA | RNA-Interference | Metafectene | publication | A. S. Timin et al., Nanomedicine: NBM 2018, 14:97-108, doi.org/10.1016/j.nano.2017.09.001 | Link | |||
DC2.4 |
Mouse dendritic cell line | Mouse | bone | cell line | siRNA | RNA-Interference | Metafectene | publication | X. You et al., Fish and Shellfish Immunology, 2018, 72: 356-366, doi.org/10.1016/j.fsi.2017.11.014 | Link | |||
DG-75 |
Human Burkitt's lymphoma cell line | ATCC CRL-2625 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | S. Thakker et al., J. Virol., May 2015; 89: 5536 - 5556 | |||
DLD-1 |
Human colon adenocarcinoma cells | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | M. Masià-Balagué et al., J. Biol. Chem., Jun 2015; 290: 15197 - 15209 | |||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
DU447 |
Human mammary adenocarcinoma cell line | Human | breast | cell line | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 |